Latisse, the first drug to promote eyelash growth has recently been approved by the FDA. Manufactured by Allergan, the same company that manufactures Botox, Latisse is available by prescription only and contains bimatoprost, the active ingredient used in the glaucoma drug Lumigan, also made by Allergan.
How To Use Latisse
Though the mechanism of action is unclear, eyelash growth is a known side effect of bimatoprost. However, Lumigan and Latisse are used differently. While Lumigan is an eyedrop, Latisse is dabbed along the lash line on the upper eyelids to promote longer, thicker, darker lashes.
A visit to Latisse’s website states that “Latisse works gradually and remarkably — starting at 4 weeks with full results after 16 weeks. Once you begin treatment, you could start to see results in as little as 4 weeks, but you must continue applying the topical treatment each night and follow the directions for best results.” Users can expect to see changes in length, thickness and darkness. If Latisse is stopped, eyelashes will gradually return to their previous appearance as new eyelashes grow in.
Latisse Safety
While Latisse tends to be well tolerated by most individuals, clinical studies showed that 4% of users experienced an itching sensation in the eyes or eye redness. Other less common side effects, typically on the skin close to where Latisse is applied or in the eyes, may also occur – skin darkening, eye irritation, dryness of the eyes and redness of the eyelids. These effects tend to be reversible with discontinuation of Latisse. Latisse may also promote hair growth in other skin areas that it frequently touches, so the manufacturer recommends that it is blotted off any skin other than the upper eyelid’s lash line to prevent that side effect.
If you’ve always wanted lush lashes, then Latisse might be right for you. However, keep in mind that this is still a very new drug that does come with some side effects. You’ll have to determine if the cost ($120 per tube) and risk of side effects is worth it.